BioCentury | Jul 10, 2019
Company News

Management tracks: Maze, Tiaki, NED, Annexon and more

...Mass.). Tiaki is developing therapeutics that target microglia to treat inflammatory-driven CNS disorders. Cancer company NED Biosystems Inc....
...and CFO of Safeguard Scientifics Inc. (NYSE:SFE). Jonathan Block, Associate Editor Annexon Biosciences Inc. Annovis Inc. Ideaya Biosciences Inc. Maze Therapeutics NED Biosystems Inc. Ocular...
Items per page:
1 - 1 of 1
BioCentury | Jul 10, 2019
Company News

Management tracks: Maze, Tiaki, NED, Annexon and more

...Mass.). Tiaki is developing therapeutics that target microglia to treat inflammatory-driven CNS disorders. Cancer company NED Biosystems Inc....
...and CFO of Safeguard Scientifics Inc. (NYSE:SFE). Jonathan Block, Associate Editor Annexon Biosciences Inc. Annovis Inc. Ideaya Biosciences Inc. Maze Therapeutics NED Biosystems Inc. Ocular...
Items per page:
1 - 1 of 1